SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Monday reported a loss of $52.3 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 55 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drug developer posted revenue of $224.6 million in the period, which beat Street forecasts. Five analysts surveyed by Zacks expected $192.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX